Sable · Question
What is the difference between Tirzepatide and Pal-GHK?
Tirzepatide is a 39-residue dual GIP and GLP-1 receptor agonist with a C20 fatty diacid moiety, studied in incretin receptor pharmacology (peptide (lipidated), MW about 4813 g/mol).
Research use only. Not for human consumption. No health claims.
Last verified 2026-10-10
What is the difference between Tirzepatide and Pal-GHK?
Tirzepatide is a 39-residue dual GIP and GLP-1 receptor agonist with a C20 fatty diacid moiety, studied in incretin receptor pharmacology (peptide (lipidated), MW about 4813 g/mol).
Which is heavier, Tirzepatide or Pal-GHK?
Tirzepatide has a molecular weight of about 4813 g/mol and Pal-GHK about 578.8 g/mol (PubChem), so Tirzepatide is heavier by 4,234.2 g/mol, a ratio of 8.32. This means 1 mg of Tirzepatide contains 207.8 nmol versus 1,727.7 nmol for Pal-GHK.
How many mg of Pal-GHK are equimolar to 1 mg of Tirzepatide?
1 mg of Tirzepatide (MW 4813) is 207.8 nmol. The same number of moles of Pal-GHK (MW 578.8) weighs 0.1203 mg. Equimolar comparisons matter when testing two compounds side by side in the same assay.
Compare the molecular formulas of Tirzepatide and Pal-GHK
PubChem lists Tirzepatide as C225H348N48O68 (4813 g/mol) and Pal-GHK as C30H54N6O5 (578.8 g/mol). Tirzepatide is a peptide (lipidated); Pal-GHK is a lipopeptide. These formulas refer to the parent compounds without salt counter-ions.
A 10 mg vial of Pal-GHK equals how many mg of Tirzepatide in moles?
10 mg of Pal-GHK (MW 578.8) is 17.277 µmol. The same amount of Tirzepatide (MW 4813) would weigh 83.155 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 20 mg vial of Tirzepatide equals how many mg of Pal-GHK in moles?
20 mg of Tirzepatide (MW 4813) is 4.155 µmol. The same amount of Pal-GHK (MW 578.8) would weigh 2.405 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 10 mg vial of Tirzepatide equals how many mg of Pal-GHK in moles?
10 mg of Tirzepatide (MW 4813) is 2.078 µmol. The same amount of Pal-GHK (MW 578.8) would weigh 1.203 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 5 mg vial of Tirzepatide equals how many mg of Pal-GHK in moles?
5 mg of Tirzepatide (MW 4813) is 1.039 µmol. The same amount of Pal-GHK (MW 578.8) would weigh 0.6013 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 30 mg vial of Tirzepatide equals how many mg of Pal-GHK in moles?
30 mg of Tirzepatide (MW 4813) is 6.233 µmol. The same amount of Pal-GHK (MW 578.8) would weigh 3.608 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 40 mg vial of Tirzepatide equals how many mg of Pal-GHK in moles?
40 mg of Tirzepatide (MW 4813) is 8.311 µmol. The same amount of Pal-GHK (MW 578.8) would weigh 4.81 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 15 mg vial of Tirzepatide equals how many mg of Pal-GHK in moles?
15 mg of Tirzepatide (MW 4813) is 3.117 µmol. The same amount of Pal-GHK (MW 578.8) would weigh 1.804 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
A 60 mg vial of Tirzepatide equals how many mg of Pal-GHK in moles?
60 mg of Tirzepatide (MW 4813) is 12.466 µmol. The same amount of Pal-GHK (MW 578.8) would weigh 7.215 mg. This equimolar conversion lets two compounds be compared at matched molar amounts in the same experiment.
More questions about tirzepatide
A CoA for every lot; each vial carries a printed lot number that matches it. Ask with the lot number and we send it.
Cite this
Research use only. Not for consumption. No health claims.
Plain
Sable Peptides. (2026). What is the difference between Tirzepatide and Pal-GHK?. UK Research Peptide Reference. Retrieved 11 October 2026, from https://www.sablepeptides.co.uk/questions/compare/pal-ghk-vs-tirzepatide/#sqa-041067
APA
Sable Peptides. (2026, October 11). *What is the difference between Tirzepatide and Pal-GHK?*. UK Research Peptide Reference. https://www.sablepeptides.co.uk/questions/compare/pal-ghk-vs-tirzepatide/#sqa-041067
BibTeX
@misc{sable_#sqa-041067_2026,
author = {{Sable Peptides}},
title = {{What is the difference between Tirzepatide and Pal-GHK?}},
year = {2026},
howpublished = {\url{https://www.sablepeptides.co.uk/questions/compare/pal-ghk-vs-tirzepatide/#sqa-041067}},
note = {Accessed 11 October 2026. CC BY 4.0}
}Badge
<a href="https://www.sablepeptides.co.uk/ref"><img src="https://www.sablepeptides.co.uk/badge/ref.svg" alt="Data: UK Research Peptide Reference — Sable Peptides" width="220" height="40"></a>
Date modified: 2026-10-10